IS PSA DENSITY OR PSA (OR NEITHER) USEFUL TO PREDICT BIOPSY RECLASSIFICATION IN ACTIVE SURVEILLANCE PATIENTS?

被引：0
|
作者：
Fazeli, Roghayeh
Mamawala, Mufaddal
Landis, Patricia
Wolf, Sacha
Carter, H. Ballentine
Trock, Bruce J.
机构：
来源：
JOURNAL OF UROLOGY | 2016年 / 195卷 / 04期
关键词：
D O I：
10.1016/j.juro.2016.02.2532
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP15-08
引用
收藏
页码：E154 / E155
页数：2
相关论文
共 50 条
  • [41] Older Age at Diagnosis and Initial Disease Volume Predict Grade Reclassification Risk on Confirmatory Biopsy in Patients Considered for Active Surveillance
    Dai, Charles
    Ganesan, Vishnu
    Nyame, Yaw A.
    Almassi, Nima
    Greene, Daniel J.
    Hettel, Daniel
    Magi-Galluzzi, Cristina
    Gong, Michael
    Jones, J. Stephen
    Stephenson, Andrew J.
    Berglund, Ryan K.
    Klein, Eric A.
    [J]. UROLOGY, 2019, 130 : 106 - 111
  • [42] Implementation of PSA-based active surveillance in prostate cancer
    Jalloh, Mohamed
    Cooperberg, Matthew R.
    [J]. BIOMARKERS IN MEDICINE, 2014, 8 (05) : 747 - 753
  • [43] Detection of prostatic carcinoma:: The role of TRUS, TRUS guided biopsy, digital rectal examination, PSA and PSA density
    Men, S
    Çakar, B
    Conkbayir, I
    Hekimoglu, B
    [J]. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2001, 20 (04) : 473 - 480
  • [44] MODELS TO PREDICT PROSTATE CANCER AGGRESSIVINESS IN PATIENTS CANDIDATES TO BIOPSY WITH PSA 2.5-10
    Gomez Veiga, F.
    Ponce, J.
    Pertega, S.
    Breijo, S.
    Dacal, J.
    Torres, M.
    Rodriguez, I.
    Lopez, D.
    Pita, S.
    Abal, V. Ch
    [J]. JOURNAL OF UROLOGY, 2011, 185 (04): : E480 - E480
  • [45] Is PSA doubling time after one year on active surveillance correlated to progression on re-biopsy in patients with low-risk prostate cancer followed on active surveillance?
    Thomsen, Frederik Birkebk
    Roder, Martin Andreas
    Hvarness, Helle
    Brasso, Klaus
    Iversen, Peter
    [J]. SCANDINAVIAN JOURNAL OF UROLOGY, 2013, 47 : 41 - 42
  • [46] Association of extent and aggressiveness of inflammation with serum PSA levels and PSA density in asymptomatic patients
    Kandirali, Eagin
    Boran, Cetin
    Serin, Erdinc
    Semercioz, Atilla
    Metin, Ahmet
    [J]. UROLOGY, 2007, 70 (04) : 743 - 747
  • [47] Reclassification prediction of first-year protocol biopsy on active surveillance of prostate cancer by p2PSA-related parameters: from PRIAS-JAPANClinical Research
    Kato, Takuma
    Hirama, Hiromi
    Mitsuzuka, Koji
    Maruyama, Satoru
    Sasaki, Hiroshi
    Saito, Toshihiro
    Matsumoto, Ryuji
    Sakamoto, Shinichi
    Sakai, Yasuyuki
    Fukuhara, Hiroshi
    Naya, Yukio
    Tsukino, Hiromasa
    Hara, Isao
    Ogawa, Osamu
    Hashine, Katsuyoshi
    Fumimasa, Fukuta
    Yokomizo, Akira
    Tohi, Yoichiro
    Kakehi, Yoshiyuki
    Sugimoto, Mikio
    [J]. PROSTATE CANCER AND PROSTATIC DISEASES, 2022, 25 (04) : 666 - 671
  • [48] NADIR PSA AND TIME TO PSA PROGRESSION PREDICT OVERALL SURVIVAL IN PATIENTS WITH METASTATIC PROSTATE CANCER
    Tomioka, A.
    Tanaka, N.
    Miyake, M.
    Inoue, T.
    Anai, S.
    Ikeda, T.
    Fujimoto, K.
    Hirao, Y.
    Konishi, N.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (02) : 77 - 77
  • [49] Assessment of Serum microRNA Biomarkers to Predict Reclassification of Prostate Cancer in Patients on Active Surveillance
    Liu, Richard S. C.
    Olkhov-Mitsel, Ekaterina
    Jeyapala, Renu
    Zhao, Fang
    Commisso, Kristina
    Klotz, Laurence
    Loblaw, Andrew
    Liu, Stanley K.
    Vesprini, Danny
    Fleshner, Neil E.
    Bapat, Bharati
    [J]. JOURNAL OF UROLOGY, 2018, 199 (06): : 1476 - 1482
  • [50] REFINED ANALYSIS OF PROSTATE SPECIFIC ANTIGEN (PSA) VELOCITY TO PREDICT OUTCOMES IN ACTIVE SURVEILLANCE: RESULTS FROM THE CANARY PROSTATE ACTIVE SURVEILLANCE STUDY (PASS)
    Cooperberg, Matthew
    Brooks, James
    Faino, Anna
    Zheng, Yingye
    Kearns, James
    Carroll, Peter
    Dash, Atreya
    Fabrizio, Michael
    Gleave, Martin
    Morgan, Todd
    Nelson, Peter
    Thompson, Ian
    Wagner, Andrew
    Newcomb, Lisa
    Lin, Daniel
    [J]. JOURNAL OF UROLOGY, 2017, 197 (04): : E558 - E558
12345